Technology in medicine is changing and can have far-reaching impact on the diagnosis, treatment, and provider of care services in the future. 1. Artificial intelligence Artificial intelligence (AI) is definited as intelligence shown by machines or application have the skill to portray or mimic the function of the human brain. In medicine, AI was developed to support the medical staff. It has the ability to remember knowledge, analyze data, remember and, through that, providing the diagnosis and solution of clinical quality and in real time. Artificial intelligence market for medical applications is believed to grow rapidly across the globe. Growth rate annual dual predicts about 42% until the year 2021. Accordingly, with the support of artificial intelligence, quality patient care will become better. Cost of treatment reduced, many unnecessary procedures are eliminated. By 2020, chronic disease types such as diabetes and cancer would be diagnosed in just a few minutes by using system, scan 3D perception characteristics, physiological typical can be built in real-time. By 2025, imaged to be available to ninety percentages of the medical facilities of the United States and sixty percentages of hospitals globally and the insurance company use system, artificial intelligence. In return, the AI system will provide medical services methods, easy care, cheaper and more quality up to seventy percentages of patients. Today, the system artificial intelligence is being developed to analyze medical images reliable and highly accurate with the help from processing digital images, pattern recognition, and platform WHO. The start-up company Butterfly Network is also developing a tool for 3D ultrasound portable, capable of sending images, real-time cloud services. Then, the characteristics will be recognised by the database and sent back the diagnosis to the patient. In addition, a creative direction is more easily, artificial intelligence can be used to take care of patients better in treatment. As the software face recognition and gesture are being developed to remind patients to take the drug. This known method is direct observation, a new market segment that probably also will soon be captured by the company artificial intelligence. 2. Immunotherapy Immunotherapy is treatment by consentrating on the immune system’s the ability rather than directly attack the tumor. This method is promising in cancer treatment. Charting new field in the duration of individual existence and the potential for important number of patients benefit. Immunotherapy is used for patients-melanoma skin cancer with the possibility of extending the first amount of many times than with traditional methods. When that there are now more than 160,000 cases of melanoma are diagnosed worldwide, of which there are 40,000 deaths per year. Immune therapy is also being studied for its wide application in many different types of cancer. The market for drugs used in immunotherapy for 2015 reached 3 billion USD. And projected to the year 2020 up to 21,1 billion USD, with growth rate annual reaches 139%. 3. Biopsy Biopsy liquid separates cancer cells from a simple blood sample and is capable of treating cancer, cancer cell tracking non-invasive. With this technology now, patients won’t have to go through the biopsy repeated as before. Technique biopsy of the fluid provides an investment opportunity attractive for companies active in the field of diagnosis. The focus on biomarkers in the blood, such as ctDNA and CTCs, is the potential to track and monitor tumors in a non invasive way. Expected in about two years, the liquid will become an adjunct to tissue biopsy. This technology has been proven to be much more effective in tracking the progression of the tumor even when the patient hasn tomography CT. 4. Technique of genetic engineering the CRISPR/Cas9 Eenetic engineering CRISPR / Cas9 can change the DNA correctly, cost effective and reliable. This technique has been put into research from 2014, and companies are rushing to provide research tools and development of methods of treatment using this technology. Sangamo Biosciences is the company most active was tested clinically by applying a artificial enzymes bearing the name Zinc-finger nucleases can detect segments of the gene desired in the DNA sequence of the organism, cohesion and change the structure of the gene is from the be effective treatment for the gene related to the disease. CRISPR Therapeutics and Editas Medicine also focus on CRISPR after receiving millions of USD venture capital investment. According to the analysis of the research project supported by the National Institute of health usa (NIH) technology, gene editing CRISPR / Cas9 is promising in the period 2013-2015. From 2013 to 2014, capital poured into this sector increased by 7 times. Phase 2014-2015, it was funding more than 3 times. This technology has overcome the many challenges with many technologies edit genes, such as RNAi, Talens and ZFN. In the next few years there will be a market of several hundred million DOLLARS. 5. 3D 3D technology has tremendous potential in health due to its ability to be customized. It can significantly reduce surgical time and medical costs. Currently, the largest application of 3D printing is production of artificial limbs (orthopedic implants) and medical devices in the dental implant and hearing aid. 3D technology can create liver, heart, ears, hands and eyes, or in units smaller function such as tissue, from there build up the whole body. This can be used for surgery to repair or replace damaged tissues and organs. According to estimates, there are more than 1 million people need kidney transplants worldwide; however, less than 5,000 people receive a kidney transplant matching. The scarcity of the constitutional bodies has led to a significant increase in organ trafficking illegal throughout the world. The business 3D printing as Stratasys Ltd., Arcam AB, Organovo Holdings Inc, Johnson & Johnson Services Inc. and Stryker can resolve this situation and expects to be able to dominate the market $ 6 billion in 2025.